Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared a...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 31; no. 9; pp. 725 - 729
Main Authors Heinonen, P, Sipilä, H, Neuvonen, K, Lönnberg, H, Cockcroft, VB, Wurster, S, Virtanen, R, Savola, MKT, Salonen, JS, Savola, JM
Format Journal Article
LanguageEnglish
Published PARIS CEDEX 15 Elsevier Masson SAS 1996
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.
AbstractList 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available alpha(2)-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.
4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.
Author Lönnberg, H
Cockcroft, VB
Sipilä, H
Savola, JM
Neuvonen, K
Salonen, JS
Wurster, S
Heinonen, P
Virtanen, R
Savola, MKT
Author_xml – sequence: 1
  givenname: P
  surname: Heinonen
  fullname: Heinonen, P
  organization: Department of Chemistry, University of Turku, 20500 Turku, Finland
– sequence: 2
  givenname: H
  surname: Sipilä
  fullname: Sipilä, H
  organization: Turku Medical PET-Center/TUCH, 20520 Turku, Finland
– sequence: 3
  givenname: K
  surname: Neuvonen
  fullname: Neuvonen, K
  organization: Department of Chemistry, University of Turku, 20500 Turku, Finland
– sequence: 4
  givenname: H
  surname: Lönnberg
  fullname: Lönnberg, H
  email: harri.lonnberg@utu.fi
  organization: Department of Chemistry, University of Turku, 20500 Turku, Finland
– sequence: 5
  givenname: VB
  surname: Cockcroft
  fullname: Cockcroft, VB
  organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland
– sequence: 6
  givenname: S
  surname: Wurster
  fullname: Wurster, S
  organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland
– sequence: 7
  givenname: R
  surname: Virtanen
  fullname: Virtanen, R
  organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland
– sequence: 8
  givenname: MKT
  surname: Savola
  fullname: Savola, MKT
  organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland
– sequence: 9
  givenname: JS
  surname: Salonen
  fullname: Salonen, JS
– sequence: 10
  givenname: JM
  surname: Savola
  fullname: Savola, JM
  organization: Orion Corporation, Orion-Farmos, Farmos Research, PO Box 425, 20101 Turku, Finland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3190661$$DView record in Pascal Francis
BookMark eNqNkD9v1DAYhy1UJK4t34AhA8OdqFv_i5MsSNUJKFIlhgLqZjn2a84oZ0d2Cgprv3gdrroRMXnw8_wsP6foJMQACL2h5JISKq8IYxzXjIt1Jzdt3bYM379AK9rIFnNWixO0OiKv0GnOPwkhtSRkhR7v5jDtIPtc6WCrcafTXps4xB_e6KEaUxwhTR5yFV0l1vUGrxmGaTcPmF1wbP1utiliVmU_aB8sBMzwPGz83lv9Jw5wUenlzpsYygu6DD_AsqUnP-o9LMg5eun0kOH183mGvn388HV7g2-_fPq8vb7FhtfthIWxTSsYaZygDAzTnPAeOseNFZb1PZOta2RHGtPpuoamF60hnDqQzMqaMn6GxGHXpJhzAqfG5Pc6zYoStYRUSyW1VFKdVH9DqvuivT1oo86liUs6GJ-PLqcdkZIWrD1gv6GPLhsPwcCRuqZdJ7_fkAITQsnWTyVADNv4EKaivvt_tdDvDzSUVr88JPVsWJ_ATMpG_-8PPQHHLqpO
CODEN EJMCA5
CitedBy_id crossref_primary_10_1016_j_bmc_2015_01_046
crossref_primary_10_1021_acs_orglett_9b00326
crossref_primary_10_1016_S1359_6446_03_02726_0
crossref_primary_10_1002_ejoc_201700198
crossref_primary_10_1007_s11426_019_9528_2
crossref_primary_10_1021_jm1006269
crossref_primary_10_1021_ol302040j
crossref_primary_10_1002_chin_199652145
crossref_primary_10_1016_j_scp_2020_100331
crossref_primary_10_1002_ejoc_200801197
Cites_doi 10.1016/0167-4889(92)90041-9
10.1002/jhet.5570220115
10.1016/S0021-9258(17)43021-3
10.1016/0160-9327(86)90093-1
10.1016/0160-5402(85)90034-8
10.1021/jo00020a002
10.1002/jcc.540100208
10.1016/0922-4106(93)90034-7
10.1016/0014-2999(91)90535-X
ContentType Journal Article
Copyright 1996 Elsevier, Paris
1996 INIST-CNRS
Copyright_xml – notice: 1996 Elsevier, Paris
– notice: 1996 INIST-CNRS
DBID 1KM
BLEPL
DTL
FCAKS
IQODW
AAYXX
CITATION
DOI 10.1016/0223-5234(96)85882-X
DatabaseName Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 1996
Pascal-Francis
CrossRef
DatabaseTitle Web of Science
CrossRef
DatabaseTitleList Web of Science

Database_xml – sequence: 1
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1768-3254
EndPage 729
ExternalDocumentID 10_1016_0223_5234_96_85882_X
3190661
A1996VH01900010
022352349685882X
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
M2Y
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCB
SCC
SDF
SDG
SES
SEW
SOC
SPC
SPCBC
SPT
SSK
SSP
SSU
SSZ
T5K
WUQ
~G-
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
AAPBV
ABPIF
ABPTK
IQODW
AAYXX
AFJKZ
CITATION
ID FETCH-LOGICAL-c358t-4cd784207f412ec2a303be9f3cd4d2bb268f76907c9a55e7b48c031fe62d65123
IEDL.DBID .~1
ISICitedReferencesCount 14
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=A1996VH01900010
ISSN 0223-5234
IngestDate Thu Sep 26 17:36:55 EDT 2024
Sun Oct 29 17:08:35 EDT 2023
Fri Nov 08 20:04:54 EST 2024
Wed Sep 18 06:08:54 EDT 2024
Fri Feb 23 02:16:50 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords silaindane
adrenergic receptor
Grignard reaction
atipamezole
semi-empirical calculation
ALPHA-2-ADRENOCEPTORS
BINDING
Human
α2-Adrenergic receptor
Imidazole derivatives
Silicon heterocycle
Rat
Nitrogen heterocycle
Rodentia
In vitro
In vivo
Vertebrata
Biological fixation
Mammalia
Structure activity relation
Animal
Affinity
Subcutaneous administration
Antagonist
Pharmacokinetics
Chemical synthesis
Language English
License CC BY 4.0
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c358t-4cd784207f412ec2a303be9f3cd4d2bb268f76907c9a55e7b48c031fe62d65123
PageCount 5
ParticipantIDs pascalfrancis_primary_3190661
webofscience_primary_A1996VH01900010CitationCount
elsevier_sciencedirect_doi_10_1016_0223_5234_96_85882_X
crossref_primary_10_1016_0223_5234_96_85882_X
webofscience_primary_A1996VH01900010
PublicationCentury 1900
PublicationDate 1996
1996-01-01
1996-1-00
PublicationDateYYYYMMDD 1996-01-01
PublicationDate_xml – year: 1996
  text: 1996
PublicationDecade 1990
PublicationPlace PARIS CEDEX 15
PublicationPlace_xml – name: PARIS CEDEX 15
– name: Oxford
PublicationTitle European journal of medicinal chemistry
PublicationTitleAbbrev EUR J MED CHEM
PublicationYear 1996
Publisher Elsevier Masson SAS
Elsevier
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier
References Karjalainen AJ, Virtanen RE, Karjalainen AL, Kurkela KOA (1987) US Patent 4,689,339
Stewart (bib3) 1989; 10
Arunlakshana, Schild (bib11) 1959; 14
Marjamäki, Ala-Uotila, Luomala, Perälä, Jansson, Jalkanen, Regan, Scheinin (bib7) 1992; 1134
Nametkin, Vdodin, Finkel'Shtein, Arkhipov, Oppengein (bib5) 1964; 154
Corriu, Henner, Massé (bib6) 1968
Halle, Pichon, Terrier (bib14) 1984; 259
(bib12) 1982
Turner, Lindell (bib4) 1991; 56
Marjamäki, Luomala, Ala-Uotila, Scheinin (bib8) 1993; 246
Savola, Virtanen (bib9) 1991; 195
McPherson (bib15) 1985; 14
Virtanen, Savola, Saano (bib10) 1989; 297
Kirk (bib13) 1985; 22
Tacke, Zilch (bib2) 1986; 10
CORRIU, R (WOS:A1968B529300068) 1968
MCPHERSON, GA (WOS:A1985ARP0300006) 1985; 14
(WOS:A1996VH01900010.1) 1987
MARJAMAKI, A (WOS:A1992HM55400011) 1992; 1134
HALLE, JC (WOS:A1984SL48600023) 1984; 259
NAMETKIN NS (WOS:A1996VH01900010.10) 1964; 154
ARUNLAKSHANA, O (WOS:A1959WT10300009) 1959; 14
TURNER, RM (WOS:A1991GH36900002) 1991; 56
STEWART, JJP (WOS:A1989T690100007) 1989; 10
CRC (WOS:A1996VH01900010.2) 1982
TACKE, R (WOS:A1986F434500006) 1986; 10
SAVOLA, JM (WOS:A1991FG22900002) 1991; 195
MARJAMAKI, A (WOS:A1993LV61300005) 1993; 246
VIRTANEN, R (WOS:A1989T500700017) 1989; 297
KIRK, KL (WOS:A1985ACW2300015) 1985; 22
Turner (10.1016/0223-5234(96)85882-X_bib4) 1991; 56
Savola (10.1016/0223-5234(96)85882-X_bib9) 1991; 195
(10.1016/0223-5234(96)85882-X_bib12) 1982
Halle (10.1016/0223-5234(96)85882-X_bib14) 1984; 259
Stewart (10.1016/0223-5234(96)85882-X_bib3) 1989; 10
Tacke (10.1016/0223-5234(96)85882-X_bib2) 1986; 10
Nametkin (10.1016/0223-5234(96)85882-X_bib5) 1964; 154
Marjamäki (10.1016/0223-5234(96)85882-X_bib8) 1993; 246
McPherson (10.1016/0223-5234(96)85882-X_bib15) 1985; 14
Marjamäki (10.1016/0223-5234(96)85882-X_bib7) 1992; 1134
10.1016/0223-5234(96)85882-X_bib1
Virtanen (10.1016/0223-5234(96)85882-X_bib10) 1989; 297
Corriu (10.1016/0223-5234(96)85882-X_bib6) 1968
Arunlakshana (10.1016/0223-5234(96)85882-X_bib11) 1959; 14
Kirk (10.1016/0223-5234(96)85882-X_bib13) 1985; 22
References_xml – volume: 154
  start-page: 383
  year: 1964
  end-page: 386
  ident: bib5
  publication-title: Dolk Akad Nau SSSR
  contributor:
    fullname: Oppengein
– volume: 14
  start-page: 48
  year: 1959
  end-page: 58
  ident: bib11
  publication-title: Br J Parmacol
  contributor:
    fullname: Schild
– start-page: 3013
  year: 1968
  end-page: 3023
  ident: bib6
  publication-title: Bull Soc Chim Fr
  contributor:
    fullname: Massé
– volume: 259
  start-page: 4142
  year: 1984
  end-page: 4146
  ident: bib14
  publication-title: J Biol Chem
  contributor:
    fullname: Terrier
– volume: 10
  start-page: 191
  year: 1986
  end-page: 197
  ident: bib2
  publication-title:
  contributor:
    fullname: Zilch
– year: 1982
  ident: bib12
  publication-title: Handbook of Chemistry and Physics
– volume: 1134
  start-page: 169
  year: 1992
  end-page: 177
  ident: bib7
  publication-title: Biochem Biophys Acta
  contributor:
    fullname: Scheinin
– volume: 14
  start-page: 213
  year: 1985
  end-page: 228
  ident: bib15
  publication-title: J Pharmacol Methods
  contributor:
    fullname: McPherson
– volume: 10
  start-page: 209
  year: 1989
  end-page: 220
  ident: bib3
  publication-title: J Comp Chem
  contributor:
    fullname: Stewart
– volume: 22
  start-page: 57
  year: 1985
  end-page: 59
  ident: bib13
  publication-title: J Heterocycl Chem
  contributor:
    fullname: Kirk
– volume: 195
  start-page: 193
  year: 1991
  end-page: 199
  ident: bib9
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Virtanen
– volume: 297
  start-page: 190
  year: 1989
  end-page: 204
  ident: bib10
  publication-title: Arch Int Pharmacodyn Ther
  contributor:
    fullname: Saano
– volume: 246
  start-page: 219
  year: 1993
  end-page: 226
  ident: bib8
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Scheinin
– volume: 56
  start-page: 5739
  year: 1991
  end-page: 5740
  ident: bib4
  publication-title: J Org Chem
  contributor:
    fullname: Lindell
– volume: 14
  start-page: 213
  year: 1985
  ident: WOS:A1985ARP0300006
  article-title: ANALYSIS OF RADIOLIGAND BINDING EXPERIMENTS - A COLLECTION OF COMPUTER-PROGRAMS FOR THE IBM-PC
  publication-title: JOURNAL OF PHARMACOLOGICAL METHODS
  contributor:
    fullname: MCPHERSON, GA
– volume: 22
  start-page: 57
  year: 1985
  ident: WOS:A1985ACW2300015
  article-title: 4-LITHIO-1-TRITYLIMIDAZOLE AS A SYNTHETIC INTERMEDIATE - SYNTHESIS OF IMIDAZOLE-4-CARBOXALDEHYDE
  publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY
  contributor:
    fullname: KIRK, KL
– volume: 259
  start-page: 4142
  year: 1984
  ident: WOS:A1984SL48600023
  article-title: SOLVENT EFFECT ON THE PROTON-BINDING SITES IN UROCANIC ACID - A TAUTOMERIC EQUILIBRIUM STUDY
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  contributor:
    fullname: HALLE, JC
– volume: 56
  start-page: 5739
  year: 1991
  ident: WOS:A1991GH36900002
  article-title: A FACILE ROUTE TO IMIDAZOL-4-YL ANIONS AND THEIR REACTION WITH CARBONYL-COMPOUNDS
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  contributor:
    fullname: TURNER, RM
– volume: 195
  start-page: 193
  year: 1991
  ident: WOS:A1991FG22900002
  article-title: CENTRAL ALPHA-2-ADRENOCEPTORS ARE HIGHLY STEREOSELECTIVE FOR DEXMEDETOMIDINE, THE DEXTRO ENANTIOMER OF MEDETOMIDINE
  publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY
  contributor:
    fullname: SAVOLA, JM
– volume: 154
  start-page: 383
  year: 1964
  ident: WOS:A1996VH01900010.10
  publication-title: COKL AKAD NAU SSSR
  contributor:
    fullname: NAMETKIN NS
– year: 1987
  ident: WOS:A1996VH01900010.1
– volume: 297
  start-page: 190
  year: 1989
  ident: WOS:A1989T500700017
  article-title: HIGHLY SELECTIVE AND SPECIFIC ANTAGONISM OF CENTRAL AND PERIPHERAL ALPHA-2-ADRENOCEPTORS BY ATIPAMEZOLE
  publication-title: ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE
  contributor:
    fullname: VIRTANEN, R
– start-page: 3013
  year: 1968
  ident: WOS:A1968B529300068
  article-title: PREPARATION AND CYCLISATION OF VINYL AND CHLOROMETHYL SILANES
  publication-title: BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE
  contributor:
    fullname: CORRIU, R
– volume: 246
  start-page: 219
  year: 1993
  ident: WOS:A1993LV61300005
  article-title: USE OF RECOMBINANT HUMAN ALPHA(2)-ADRENOCEPTORS TO CHARACTERIZE SUBTYPE SELECTIVITY OF ANTAGONIST BINDING
  publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION
  contributor:
    fullname: MARJAMAKI, A
– volume: 1134
  start-page: 169
  year: 1992
  ident: WOS:A1992HM55400011
  article-title: STABLE EXPRESSION OF RECOMBINANT HUMAN ALPHA-2-ADRENOCEPTOR SUBTYPES IN 2 MAMMALIAN-CELL LINES - CHARACTERIZATION WITH [H-3] RAUWOLSCINE BINDING, INHIBITION OF ADENYLATE-CYCLASE AND RNASE PROTECTION ASSAY
  publication-title: BIOCHIMICA ET BIOPHYSICA ACTA
  contributor:
    fullname: MARJAMAKI, A
– volume: 10
  start-page: 191
  year: 1986
  ident: WOS:A1986F434500006
  article-title: SILA-SUBSTITUTION - A USEFUL STRATEGY FOR DRUG DESIGN
  publication-title: ENDEAVOUR
  contributor:
    fullname: TACKE, R
– year: 1982
  ident: WOS:A1996VH01900010.2
  publication-title: HDB CHEM PHYS
  contributor:
    fullname: CRC
– volume: 10
  start-page: 209
  year: 1989
  ident: WOS:A1989T690100007
  article-title: OPTIMIZATION OF PARAMETERS FOR SEMIEMPIRICAL METHODS .1. METHOD
  publication-title: JOURNAL OF COMPUTATIONAL CHEMISTRY
  contributor:
    fullname: STEWART, JJP
– volume: 14
  start-page: 48
  year: 1959
  ident: WOS:A1959WT10300009
  article-title: SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
  publication-title: BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY
  contributor:
    fullname: ARUNLAKSHANA, O
– volume: 297
  start-page: 190
  year: 1989
  ident: 10.1016/0223-5234(96)85882-X_bib10
  publication-title: Arch Int Pharmacodyn Ther
  contributor:
    fullname: Virtanen
– volume: 1134
  start-page: 169
  year: 1992
  ident: 10.1016/0223-5234(96)85882-X_bib7
  publication-title: Biochem Biophys Acta
  doi: 10.1016/0167-4889(92)90041-9
  contributor:
    fullname: Marjamäki
– volume: 14
  start-page: 48
  year: 1959
  ident: 10.1016/0223-5234(96)85882-X_bib11
  publication-title: Br J Parmacol
  contributor:
    fullname: Arunlakshana
– volume: 22
  start-page: 57
  year: 1985
  ident: 10.1016/0223-5234(96)85882-X_bib13
  publication-title: J Heterocycl Chem
  doi: 10.1002/jhet.5570220115
  contributor:
    fullname: Kirk
– volume: 259
  start-page: 4142
  year: 1984
  ident: 10.1016/0223-5234(96)85882-X_bib14
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)43021-3
  contributor:
    fullname: Halle
– volume: 10
  start-page: 191
  year: 1986
  ident: 10.1016/0223-5234(96)85882-X_bib2
  publication-title: Endeavour, New Series
  doi: 10.1016/0160-9327(86)90093-1
  contributor:
    fullname: Tacke
– volume: 14
  start-page: 213
  year: 1985
  ident: 10.1016/0223-5234(96)85882-X_bib15
  publication-title: J Pharmacol Methods
  doi: 10.1016/0160-5402(85)90034-8
  contributor:
    fullname: McPherson
– volume: 56
  start-page: 5739
  year: 1991
  ident: 10.1016/0223-5234(96)85882-X_bib4
  publication-title: J Org Chem
  doi: 10.1021/jo00020a002
  contributor:
    fullname: Turner
– volume: 154
  start-page: 383
  year: 1964
  ident: 10.1016/0223-5234(96)85882-X_bib5
  publication-title: Dolk Akad Nau SSSR
  contributor:
    fullname: Nametkin
– ident: 10.1016/0223-5234(96)85882-X_bib1
– volume: 10
  start-page: 209
  year: 1989
  ident: 10.1016/0223-5234(96)85882-X_bib3
  publication-title: J Comp Chem
  doi: 10.1002/jcc.540100208
  contributor:
    fullname: Stewart
– volume: 246
  start-page: 219
  year: 1993
  ident: 10.1016/0223-5234(96)85882-X_bib8
  publication-title: Eur J Pharmacol
  doi: 10.1016/0922-4106(93)90034-7
  contributor:
    fullname: Marjamäki
– year: 1982
  ident: 10.1016/0223-5234(96)85882-X_bib12
– volume: 195
  start-page: 193
  year: 1991
  ident: 10.1016/0223-5234(96)85882-X_bib9
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(91)90535-X
  contributor:
    fullname: Savola
– start-page: 3013
  year: 1968
  ident: 10.1016/0223-5234(96)85882-X_bib6
  publication-title: Bull Soc Chim Fr
  contributor:
    fullname: Corriu
SSID ssj0005600
Score 1.5940189
Snippet 4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and...
4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and...
Source Web of Science
SourceID crossref
pascalfrancis
webofscience
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 725
SubjectTerms adrenergic receptor
atipamezole
Biological and medical sciences
Catecholaminergic system
Chemistry, Medicinal
Grignard reaction
Life Sciences & Biomedicine
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology & Pharmacy
Pharmacology. Drug treatments
Science & Technology
semi-empirical calculation
silaindane
Title Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole
URI https://dx.doi.org/10.1016/0223-5234(96)85882-X
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=A1996VH01900010
Volume 31
WOS A1996VH01900010
WOSCitedRecordID wosA1996VH01900010
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pi9QwFA6yHhREdFUcdZcclmUGJo5N07Q9LoPLqLgsuCu9lfxkC7OdMh0P9eDFf9z3-mNmFhTFa5M2Id_re98LeV8IOYkC74EZOxYb55mIpWI6TQTzHBJsbkJpAiwU_nwhF9fiYxZle7UweKyy9_2dT2-9df9k1q_mrCqKGQQfIA-od55EQBMzLGCH6Acm_fbH3ikP2VWhQGfMucRQPRfI2fbZOJWT9hss-1N0elSpGtbMd5dd_DZItQHp_Al53DNJetZN9im558pD8mA-XOB2SE4vO1nqZkqvdlVW9ZSe0sudYHXzjPz80pTAA-uipqq0tNo1IoK0wv36NQqv0pWnYhxN2JgzBwgvGZ-GzBY3jV2vGKd1sVQov1gyzprlpLgtrPq-WropVdgGRlfCCN12EX4LrKJStw67PCfX5--v5gvWX87ATBglGyaMjRPB38VeBNwZriAWapf60FhhudZcJj7G1NukKopcrEViwIF4J7mVwDLCF-SgXJXuJaER2INNJHROjFCR1tLKVEAeEwNZ0qkYETaAkledBkc-HE5DEHMEMU9l3oKYZyMSD8jld2wphzDxlzeP7gC9HQ4cFXCzYERO9oHfNqN2sPy6wLp8TLJHJPiXbvNehR3VBzav_nvSr8nD7ig57gu9IQeb9Td3BExpo4_bf-GY3D_78Glx8QuXRw4D
link.rule.ids 315,783,787,4031,4509,24128,27935,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLZgHIaEEAwQBQY-TFMr1ZQ4jpMcUcVUYJsm0aHcIsc_tEhdGjXdITtw4R_nvfxoOwkE4ho7seXv5b3vWX6fCTkKPOeAGVsWauuYCKViWRwJ5jgk2Fz7UntYKHx2LmeX4ksSJDu1MHissvP9rU9vvHX3ZNKt5qTM8wkEHyAPqHceBUATk_vkgUB6DDb9_sfOMQ_ZlqFAb0y6RF8-58nJ5tkwlqPmIyz5U3h6VKoKFs21t138Nko1EenkCXncUUn6sZ3tU3LPFgdkf9rf4HZAji9aXep6TOfbMqtqTI_pxVaxun5Gfn6rCyCCVV5RVRhabhsRQlrihv0KlVfp0lExDEZsyJkFiBeMj31m8qvarJaM0ypfKNRfLBhn9WKUX-dG3S4XdkwVtoHVFTBCu1-E3wKzKNW1xS7PyeXJp_l0xrrbGZj2g2jNhDZhJPiH0AmPW80VBMPMxs7XRhieZVxGLsTcW8cqCGyYiUiDB3FWciOBZvgvyF6xLOxLQgMwCBNJ6BxpoYIsk0bGAhKZENhSFosBYT0oadmKcKT96TQEMUUQ01imDYhpMiBhj1x6x5hSiBN_efPwDtCb4cBTATnzBuRoF_hNM4oHy-8zLMzHLHtAvH_pNu1k2FF-YP3qvyf9juzP5men6enn86-vycP2XDluEr0he-vVjT0E2rTO3jb_xS_GkA-c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+pharmacological+properties+of+4%285%29-%282-ethyl-2%2C3-dihydro-2+silainden-2-yl%29imidazole%2C+a+silicon+analogue+of+atipamezole&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Heinonen%2C+P&rft.au=Sipil%C3%A4%2C+H&rft.au=Neuvonen%2C+K&rft.au=L%C3%B6nnberg%2C+H&rft.date=1996&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=31&rft.issue=9&rft.spage=725&rft.epage=729&rft_id=info:doi/10.1016%2F0223-5234%2896%2985882-X&rft.externalDocID=022352349685882X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon